Fulminant Hepatic Failure

Fingerote, Robert J.; Bain, Vincent G.
July 1993
American Journal of Gastroenterology;Jul1993, Vol. 88 Issue 7, p1000
Academic Journal
Fulminant hepatic failure (FHF) is defined as acute liver failure with hepatic encephalopathy in patients with no history or stigmata of chronic liver disease. Historically, its prognosis was extremely poor. However, the emergence of orthotopic liver transplantation as a viable form of therapy for liver failure and advances in intensive care medicine have improved patient survival dramatically. Treatment of this condition revolves around supportive medical care and timely referral for orthoepic liver transplantation as necessary. Treatment needs to be individualized for each patient, because prognosis varies, depending on the etiology of the condition. The clinical manifestations of FHF and the management of (his condition are discussed. Future prospects for the management of FHF are also reviewed.


Related Articles

  • New strategies for treating hepatic encephalopathy. Gómez-Gutiérrez, Cristina; Manzano-Robleda, María C.; Uribe, Misael; Méndez-Sánchez, Nahum // Annals of Hepatology: Official Journal of the Mexican Associatio;2014, Vol. 13 Issue 3, p409 

    The article comments on the use of new techniques in treating hepatic encephalopathy (HE), a serious neuropsychiatric complication of both acute and chronic liver disease. The role of ammonia accumulation has ed explanations of the pathogenesis of HE. General management of HE focuses on...

  • USE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A BRIDGE TO TRANSPLANTATION IN FULMINANT HEPATIC FAILURE DUE TO BUDD-CHIARI SYNDROME. Shrestha, Roshan; Durham, Janette D.; Wachs, Michael; Bilir, Bahri M.; Kam, Igal; Trouillot, Thomas; Everson, Gregory T. // American Journal of Gastroenterology;Dec1997, Vol. 92 Issue 12, p2304 

    We report a case of fulminant hepatic failure in a 55-yr-old man due to Budd-Chiari syndrome in the setting of polycythemia rubra vera. The patient presented with acute hepatic failure, which rapidly progressed to grade IV hepatic encephalopathy. Placement of a transjugular intrahepatic...

  • Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees. Nakayama, Nobuaki; Oketani, Makoto; Kawamura, Yoshihiro; Inao, Mie; Nagoshi, Sumiko; Fujiwara, Kenji; Tsubouchi, Hirohito; Mochida, Satoshi // Journal of Gastroenterology;Jun2012, Vol. 47 Issue 6, p664 

    Background: We established algorithms to predict the prognosis of acute liver failure (ALF) patients through a data-mining analysis, in order to improve the indication criteria for liver transplantation. Methods: The subjects were 1,022 ALF patients seen between 1998 and 2007 and enrolled in a...

  • Pathogenesis and Treatment of Chronic Hepatic Encephalopathy. Häussinger, Dieter // Digestion;1998 Supplement 2, Vol. 59, p25 

    Although there is general agreement that hepatic encephalopathy (HE) is functional in nature, its pathogenesis has not yet been elucidated. A variety of mechanisms have been implicated such as the action of ammonia and other neurotoxins, disturbances of the blood-brain barrier and alterations of...

  • Hepatology -- Guidelines on Parenteral Nutrition, Chapter 16. Plauth, M.; Schuetz, T. // GMS German Medical Science;2009, Vol. 7, p1 

    Parenteral nutrition (PN) is indicated in alcoholic steatohepatitis (ASH) and in cirrhotic patients with moderate or severe malnutrition. PN should be started immediately when sufficientl oral or enteral feeding is not poßible. ASH and cirrhosis patients who can be sufficiently fed either...

  • Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. Heidelbaugh, Joel J.; Bruderly, Michael // American Family Physician;9/1/2006, Vol. 74 Issue 5, p767 

    Major complications of cirrhosis include ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, portal hypertension, variceal bleeding, and hepatorenal syndrome. Diagnostic studies on ascitic fluid should include a differential leukocyte count, total protein level, a serum-ascites...

  • Reversibility of hepatic encephalopathy after liver transplantation. Atluri, Dileep K.; Asgeri, Mehrdad; Mullen, Kevin D. // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p111 

    Until the advent of Liver transplantation, it was widely believed that Hepatic Encephalopathy (HE) was usually reversible. The exceptions were the so called “Acquired Hepatocerebral Degeneration cases” which were considered irreversible. Paradoxically, it seems, with liver...

  • Chlorzoxazone.  // Reactions Weekly;10/27/2007, Issue 1175, p11 

    The article describes the case of a 48-year-old woman who developed fulminant liver failure during treatment with chlorzoxazone for shoulder pain. On examination, the woman, who had been receiving chlorzoxazone three times daily for the last 4 months, had scleral jaundice and a tender right...

  • A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. Rössle, Martin; Ochs, Andreas; Gülberg, Veit; Siegerstetter, Volker; Holl, Joseph; Deibert, Peter; Olschewski, Manfred; Reiser, Maximilian; Gerbes, Alexander L. // New England Journal of Medicine;06/08/2000, Vol. 342 Issue 23, p1701 

    Background: In patients with cirrhosis and ascites, creation of a transjugular intrahepatic portosystemic shunt may reduce the ascites and improve renal function. However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain. Methods: We randomly assigned...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics